首页>
外国专利>
Regulation of sAPP, sAPP alpha and BDNF levels in patients diagnosed with FXS and ASD
Regulation of sAPP, sAPP alpha and BDNF levels in patients diagnosed with FXS and ASD
展开▼
机译:诊断为FXS和ASD的患者中sAPP,sAPPα和BDNF水平的调节
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting the amount of a therapeutic compound according to the plasma levels of BDNF, sAPP and sAPPs. In one embodiment, the therapeutic compound is acamprosate.
展开▼